Clearmind Medicine (CMND) Payables (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Payables of $405315.0 for Q2 2026, up 195.76% year-over-year from $137042.0 in Q2 2025, and up 27.54% quarter-over-quarter from $317783.0 in Q1 2026.
Clearmind Medicine (CMND) Payables (2021 - 2026) Analysis & Trends
Clearmind Medicine's Payables history runs 6 years deep, the most recent figure standing at $405315.0 for Q2 2026.
- In Q2 2026, Payables rose 195.76% year-over-year to $405315.0; the TTM figure through Apr 2026 stood at $405315.0 (up 195.76% YoY), while the FY2025 annual figure was $286488.0, up 117.3% from the prior year.
- Payables for Q2 2026 stood at $405315.0, up from $317783.0 in the prior quarter.
- The five-year high for Payables was $1.4 million in Q4 2022, with the low at $85382.0 in Q1 2024.
- The 5-year median for Payables is $140266.0 (2025), against an average of $302374.8.
- The sharpest annual moves came in 2022 and 2023: Payables soared 386.57% in 2022, then sank 89.93% in 2023.
- Clearmind Medicine's Payables stood at $1.4 million in 2022, then tumbled by 89.93% to $136002.0 in 2023, then fell by 3.06% to $131839.0 in 2024, then surged by 117.3% to $286488.0 in 2025, then soared by 41.48% to $405315.0 in 2026.
- Business Quant data shows CMND's Payables at $405315.0 in Q2 2026, $317783.0 in Q1 2026, and $286488.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | 97,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 405,315.00 |
| Jan 31, 2026 | 317,783.00 |
| Oct 31, 2025 | 286,488.00 |
| Jul 31, 2025 | 174,043.00 |
| Apr 30, 2025 | 137,042.00 |
| Jan 31, 2025 | 143,490.00 |
| Oct 31, 2024 | 131,839.00 |
| Jul 31, 2024 | 108,597.00 |
| Apr 30, 2024 | 105,022.00 |
| Jan 31, 2024 | 85,382.00 |
| Oct 31, 2023 | 136,002.00 |
| Jul 31, 2023 | 126,661.00 |
| Jan 31, 2023 | 725,221.64 |
| Oct 31, 2022 | 1.35 Mn |
| Oct 31, 2021 | 277,524.26 |